This Article Full Text Full Text (PDF) All Versions of this Article: 24/5/858    most recent 01.ATV.0000126375.60073.74v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vogl-Willis, C. A. Articles by Edwards, I. J. Search for Related Content PubMed PubMed Citation Articles by Vogl-Willis, C. A. Articles by Edwards, I. J. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Compound via MeSH Substance via MeSH Hazardous Substances DB GLUCOSE Related Collections Pathophysiology Risk Factors Cell biology/structural biology Other diabetes Endothelium/vascular type/nitric oxide Mechanism of atherosclerosis/growth factors Other Vascular biology

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:858.)
© 2004 American Heart Association, Inc.

Vascular Biology

High Glucose–Induced Alterations in Subendothelial Matrix Perlecan Leads to Increased Monocyte Binding

Catherine A. Vogl-Willis; Iris J. Edwards

From the Department of Pathology, Wake Forest University School of Medicine, Winston-Salem, NC.

Correspondence to Dr Iris J. Edwards, Department of Pathology, Wake Forest University School of Medicine, Winston-Salem, NC 27157. E-mail iedwards{at}wfubmc.edu

Objective— Hyperglycemia is an independent risk factor for cardiovascular disease in diabetic patients, although the link between the two is unknown. These studies were designed to model effects of high glucose on an early event in atherogenesis: the binding of monocytes to subendothelial matrix (SEM).

Methods and Results— SEM was prepared from human bovine aortic endothelial cells (HAECs) and bovine aortic endothelial cells (BAECs) cultured in the presence of low (5 mmol/L) or high (30 mmol/L) glucose for 3 to 5 days. Monocyte binding was significantly higher (P<0.05) to the SEM of both HAEC and BAEC exposed to high glucose. This increase was a result of changes in SEM heparan sulfate proteoglycans (HSPGs). Metabolic radiolabeling of BAEC demonstrated a 24% decrease in [³⁵S]sulfate incorporation into SEM HSPG produced by cells incubated in 30 mmol/L versus 5 mmol/L glucose, whereas no glucose-associated differences were measured in [³⁵S]methionine incorporation into proteoglycans (PGs) or non-PG proteins. Autoradiography revealed 2 high-molecular weight SEM HSPGs. One was a hybrid PG that contained both heparan sulfate and chondroitin sulfate/dermatan sulfate chains. Both PGs were identified by Western blotting as perlecan.

Conclusions— These results illustrate that hyperglycemia-induced structural changes in perlecan may result in a SEM that is more favorable to retention of monocytes.

Key Words: perlecan • endothelial cell • monocyte binding • diabetes • hyperglycemia

This article has been cited by other articles:

				C. Gotting, J. Kuhn, and K. Kleesiek Serum Xylosyltransferase Activity in Diabetic Patients as a Possible Marker of Reduced Proteoglycan Biosynthesis Diabetes Care, October 1, 2008; 31(10): 2018 - 2019. [Abstract] [Full Text] [PDF]